Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas-Reference-Cited by-同舟云学术

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas

Published:2015-10-20 Issue:41 Volume:6 Page:43594-43604
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Smaglo Brandon G.¹,Tesfaye Anteneh²,Halfdanarson Thorvardur R.³,Meyer Joshua E.⁴,Wang Jue⁵,Gatalica Zoran⁶,Reddy Sandeep⁶,Arguello David⁶,Boland Patrick M.⁷

Affiliation:

1. The Ruesch Center for the Cure of GI Cancers, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA

2. Departments of Hematology/Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA

3. Department of Medicine, Mayo Clinic, Rochester, MN, USA

4. Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

5. Division of Oncology, University of Arizona Cancer Center, Phoenix, AZ, USA

6. Department of Pathology, Caris Life Sciences, Phoenix, AZ, USA

7. Department of Medicine, GI Center, Roswell Park Cancer Institute, Buffalo, NY, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome and microbiome-immune changes across preinvasive and invasive anal cancer lesions;JCI Insight;2024-07-18

2. Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances;Molecular Diagnosis & Therapy;2024-01-24

3. Mutational Signature Changes in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal;The Oncologist;2023-12-16

4. Recent Advances in the Management of Anal Cancer;Healthcare;2023-11-21

5. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection;International Journal of Cancer;2023-10-31